Filing Flows › Organon (OGN) › Q1 2025
Organon (OGN) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 2, 2025
Organon (OGN) reported revenue of $1.5B for the first quarter 2025 (Q1 2025), -7% from a year earlier and -5% from the quarter before. Operating margin was 6.7%, net earnings $87.0M (5.8% of revenue).
Organon, Q1 2025: revenue $1.5B (-7% year over year), operating margin 6.7%, net earnings $87.0M, operating cash flow $75.0M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5B | -5% | -7% |
| Gross profit | $841M | -6% | -12% |
| Operating profit | $101M | -22% | -57% |
| Net earnings | $87.0M | -20% | -57% |
| Operating cash flow | $75.0M | -81% | -1% |
| Free cash flow | $43.0M | -87% | +43% |
What changed
Revenue was $1.5B in Q1 2025, down 7% year over year and down 5% from the previous quarter.
Gross margin was 55.6%, down 3.4 points from a year earlier. Operating profit was $0.10B, a 6.7% margin (down 7.9 points year over year). Operating expenses grew 3% against a revenue fall of 7%. The fastest-growing cost line was Other operating costs (+26%). Net earnings were $0.09B, down 57% year over year. The effective tax rate was 13.9%.
Operating cash flow was $0.07B (down 1% year over year), 86% of net earnings. Non-cash charges added back $0.03B of depreciation and $0.02B of share-based compensation. Working capital and other items used $0.07B. Capital expenditures of $0.03B left free cash flow of $0.04B.
Questions
What was Organon's revenue in the first quarter 2025?
Organon (OGN) reported revenue of $1.5B for the first quarter 2025 (Q1 2025), -7% from a year earlier and -5% from the quarter before.
Was Organon profitable in the first quarter 2025?
Operating profit was $101M (6.7% of revenue) and net earnings $87.0M.
Source: Organon 10-Q on SEC EDGAR.